Department of General Radiology, Interventional Radiology and Neuroradiology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.
Eur J Radiol. 2013 Apr;82(4):686-92. doi: 10.1016/j.ejrad.2012.11.029. Epub 2012 Dec 14.
The aim of the study was to evaluate early metabolic changes using proton MR spectroscopy (MRS) in asymptomatic HIV-1-positive and HCV-positive patients without abnormalities in the structural MR examination.
Sixty-five asymptomatic patients: 21 HIV-1-positive naive, 20 HIV-1-positive with combination antiretroviral therapy (cART), 9 HIV-1/HCV-positive naive, 15 HCV-positive naive and 18 normal subjects were enrolled in the study. The MRS examinations were performed with a 1.5T MR scanner. Voxels were located in the following regions: posterior cingulate gyrus (PCG), anterior cingulate gyrus (ACG), parietal white matter (PWM), left basal ganglia (BG) and frontal white matter (FWM). The NAA/Cr, Cho/Cr, mI/Cr ratios and correlations of MRS measurements with the immunologic data were analyzed.
There was a significant decrease (p<0.05) of the NAA/Cr ratios in PCG, ACG and PWM regions in HIV-1-positive cART treated patients compared to the normal subjects. The significantly decreased NAA/Cr ratios in PWM and FWM were observed in HCV infected patients. The subjects with HIV-1/HCV co-infection revealed significantly lower NAA/Cr ratios in the ACG area. Other metabolite ratios in all analyzed regions, as well as the NAA/Cr ratios in BG showed no significant differences. The decrease of CD4n T cell count was associated with the decease of the NAA/Cr ratio in the PCG area and the increase of Cho/Cr ratio in the FWM region.
The metabolic changes - reduction of NAA/Cr ratios are most pronounced in HIV-1-positive patients using cART. The low CD4n T cell count is a risk factor for neurocognitive impairment in HIV-1-positive patients.
本研究旨在评估无症状 HIV-1 阳性和 HCV 阳性患者的早期代谢变化,这些患者的结构磁共振检查无异常。
本研究纳入了 65 例无症状患者:21 例 HIV-1 阳性初治患者、20 例 HIV-1 阳性接受联合抗逆转录病毒治疗(cART)的患者、9 例 HIV-1/HCV 阳性初治患者、15 例 HCV 阳性初治患者和 18 例正常对照者。MRS 检查在 1.5T 磁共振扫描仪上进行。在以下区域定位体素:后扣带回(PCG)、前扣带回(ACG)、顶叶白质(PWM)、左侧基底节(BG)和额白质(FWM)。分析 MRS 测量值的 NAA/Cr、Cho/Cr、mI/Cr 比值与免疫数据的相关性。
与正常对照组相比,HIV-1 阳性接受 cART 治疗的患者的 PCG、ACG 和 PWM 区域的 NAA/Cr 比值显著降低(p<0.05)。HCV 感染患者的 PWM 和 FWM 区域的 NAA/Cr 比值显著降低。HIV-1/HCV 合并感染患者的 ACG 区域的 NAA/Cr 比值显著降低。所有分析区域的其他代谢物比值以及 BG 中的 NAA/Cr 比值均无显著差异。CD4n T 细胞计数的减少与 PCG 区域的 NAA/Cr 比值降低以及 FWM 区域的 Cho/Cr 比值增加相关。
在使用 cART 的 HIV-1 阳性患者中,代谢变化——NAA/Cr 比值降低最为明显。低 CD4n T 细胞计数是 HIV-1 阳性患者发生神经认知功能障碍的危险因素。